Rhumbline Advisers Care Dx, Inc. Transaction History

Rhumbline Advisers

$105 Billion
Q2 2024

A detailed history of Rhumbline Advisers transactions in Care Dx, Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 84,159 shares of CDNA stock, worth $1.95 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

84,159

Previous 87,805 4.15%

Holding current value

$1.95 Million

Previous $929,000 40.58%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 01, 2024	SELL	$7.56 - $16.15 $27,563 - $58,882	-3,646 Reduced 4.15%	84,159 $1.31 Million
Q1 2024 May 09, 2024	BUY	$7.96 - $12.37 $4,975 - $7,731	625 Added 0.72%	87,805 $929,000
Q4 2023 Feb 08, 2024	SELL	$4.9 - $12.86 $10,407 - $27,314	-2,124 Reduced 2.38%	87,180 $1.05 Million
Q3 2023 Nov 09, 2023	SELL	$7.0 - $11.26 $9,464 - $15,223	-1,352 Reduced 1.49%	89,304 $625,000
Q2 2023 Aug 08, 2023	BUY	$7.61 - $9.46 $169,246 - $210,390	22,240 Added 32.51%	90,656 $770,000
Q1 2023 May 11, 2023	BUY	$8.83 - $17.61 $13,324 - $26,573	1,509 Added 2.26%	68,416 $625,000
Q4 2022 Feb 14, 2023	BUY	$10.88 - $20.05 $22,053 - $40,641	2,027 Added 3.12%	66,907 $763,000
Q3 2022 Nov 10, 2022	BUY	$16.06 - $26.39 $55,953 - $91,942	3,484 Added 5.67%	64,880 $1.1 Million
Q2 2022 Aug 11, 2022	BUY	$20.49 - $39.72 $128,390 - $248,885	6,266 Added 11.37%	61,396 $1.32 Million
Q1 2022 May 12, 2022	BUY	$28.19 - $46.6 $13,559 - $22,414	481 Added 0.88%	55,130 $2.04 Million
Q4 2021 Feb 10, 2022	SELL	$41.2 - $73.6 $25,626 - $45,779	-622 Reduced 1.13%	54,649 $2.49 Million
Q3 2021 Nov 12, 2021	BUY	$59.15 - $91.99 $102,388 - $159,234	1,731 Added 3.23%	55,271 $3.5 Million
Q2 2021 Aug 05, 2021	SELL	$63.02 - $95.11 $135,556 - $204,581	-2,151 Reduced 3.86%	53,540 $4.9 Million
Q1 2021 May 06, 2021	SELL	$57.62 - $95.6 $289,770 - $480,772	-5,029 Reduced 8.28%	55,691 $3.79 Million
Q4 2020 Feb 10, 2021	BUY	$41.43 - $77.09 $113,932 - $211,997	2,750 Added 4.74%	60,720 $4.4 Million
Q3 2020 Nov 12, 2020	SELL	$30.88 - $37.94 $270,817 - $332,733	-8,770 Reduced 13.14%	57,970 $2.2 Million
Q2 2020 Aug 13, 2020	BUY	$18.95 - $35.43 $176,007 - $329,073	9,288 Added 16.17%	66,740 $2.37 Million
Q1 2020 May 06, 2020	BUY	$13.94 - $28.25 $5,213 - $10,565	374 Added 0.66%	57,452 $1.25 Million
Q4 2019 Feb 05, 2020	BUY	$19.24 - $28.41 $44,290 - $65,399	2,302 Added 4.2%	57,078 $1.23 Million
Q3 2019 Oct 23, 2019	BUY	$20.03 - $40.08 $11,697 - $23,406	584 Added 1.08%	54,776 $1.24 Million
Q2 2019 Aug 14, 2019	BUY	$25.78 - $39.77 $202,321 - $312,114	7,848 Added 16.93%	54,192 $1.95 Million
Q1 2019 May 01, 2019	BUY	$22.09 - $39.21 $21,802 - $38,700	987 Added 2.18%	46,344 $1.46 Million
Q4 2018 Jan 31, 2019	BUY	$19.89 - $30.02 $313,307 - $472,875	15,752 Added 53.21%	45,357 $1.14 Million
Q3 2018 Nov 07, 2018	SELL	$12.1 - $28.85 $14,374 - $34,273	-1,188 Reduced 3.86%	29,605 $854,000
Q2 2018 Aug 06, 2018	BUY	$7.93 - $15.79 $244,188 - $486,221	30,793 New	30,793 $377,000

Others Institutions Holding CDNA

# of Institutions

167

Shares Held

49.8M

Call Options Held

60.8K

Put Options Held

34.9K

View Full List

About CareDx, Inc.

Ticker CDNA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 53,458,100
Market Cap $1.24B
Description
CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...

More about CDNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Account

Rhumbline Advisers Care Dx, Inc. Transaction History